Department of Nursing, Faculty of Human Movement and Quality of Life Sciences, University of Peloponnese, Orthias Artemidos and Plataion, 231 00, Sparta, Greece.
Mol Diagn Ther. 2014 Jun;18(3):309-14. doi: 10.1007/s40291-013-0080-1.
The ability of Yersinia species to produce biofilms has not been hitherto systematically studied, although there is evidence, that Y. enterocolitica is able to form biofilms on inanimate surfaces. The present study aimed to detect the production of biofilms by 60 clinical strains of Y. enterocolitica and to compare the antimicrobial susceptibility of planktonic versus biofilm-forming bacteria.
Y. enterocolitica strains were collected from stool and blood cultures collected from β-thalassaemic children, with gastroenteritis and/or septicemia. The isolated bacterial strains were grouped by biotyping and serotyping and the antimicrobial susceptibility of the planktonic forms was investigated by MIC determination. Biofilm formation was detected by the use of silicone disks and for the biofilm forming strains the minimum inhibitory concentration for bacterial regrowth (MICBR) of 11 clinically important antimicrobials was determined. The presence of the waaE, a gene reported to be related with biofilm formation was investigated in all the strains.
All of 60 strains were positive for biofilm production by the use of silicone disks. The great majority of the biofilm forms were resistant to all the antimicrobials. In antimicrobial concentrations far higher than the CLSI breakpoints, bacterial regrowth from the biofilms was still possible. None of the strains bore the waaE gene.
These results, indicate that biofilm formation by Y. enterocolitica might be an inherent feature. The presence of biofilms increased dramatically the MICBR in all antimicrobials. The way in which biofilms could contribute to Y. enterocolitica pathogenicity in humans is a matter needing further investigation.
虽然有证据表明肠耶尔森菌能够在无生命表面形成生物膜,但迄今为止,尚未对耶尔森氏菌属产生生物膜的能力进行系统研究。本研究旨在检测 60 株临床分离的肠耶尔森菌产生生物膜的能力,并比较浮游菌与生物膜形成菌对抗菌药物的敏感性。
从β-地中海贫血儿童的胃肠炎和/或败血症粪便和血液培养物中收集肠耶尔森菌菌株。将分离的细菌菌株按生物分型和血清分型进行分组,并通过 MIC 测定法研究浮游形式的抗菌药物敏感性。通过使用硅酮圆盘检测生物膜形成,对于生物膜形成菌株,确定 11 种临床重要抗菌药物的细菌再生长最低抑制浓度(MICBR)。调查了所有菌株中与生物膜形成相关的 waaE 基因的存在情况。
所有 60 株菌株均通过硅酮圆盘证实了生物膜的形成。绝大多数生物膜形式对所有抗菌药物均具有抗性。在远高于 CLSI 折点的抗菌药物浓度下,仍可从生物膜中重新生长细菌。没有菌株携带 waaE 基因。
这些结果表明,肠耶尔森菌生物膜的形成可能是固有特征。生物膜的存在使所有抗菌药物的 MICBR 大大增加。生物膜如何促进人类肠耶尔森菌的致病性是一个需要进一步研究的问题。